Tuesday - August 11, 2026

REGENERON PHARMACEUTICALS Gains $2.94 Billion Contract Modification

Copyright © Targeted News Service 2021
2021-09-16
WASHINGTON, Sept. 16 -- The U.S. Army Contracting Command issued the following high-value contract information through the Pentagon on Sept. 14, 2021:

REGENERON PHARMACEUTICALS, Tarrytown, New York, was awarded a $2,940,000,000 modification to a contract (W15QKN-21-C-0014) for 1,400,000 Regen-Cov antibody therapeutic doses.

The U.S. Army Contracting Command, Aberdeen Proving Ground, Maryland, is the contracting activity. [DODBT] . . .

Targeted News Service Information Request Form

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Organization Name:
Email:
Phone:
State:
I'd like to have a copy of this article mailed to me.

Request a free sample

Check any of the products below to receive a free sample via email.
1 - State Newsletters
2 - Federal Contract Awards
3 - Federal Solicitations (by product/service) **
4 - Federal Grant Opportunities (by eligible recipient/topic category) **
5 - U.S. Patent Awards
Check the products below that interest you and a representative will be in touch shortly.
5 - U.S. Patent Awards
6 - Congressional Votes (by state delegation)
7 - NewsFocus Newsletter (by YOUR subject topic) **
8 - Congressional Bill Introductions
9 - Customized services (we'll be in touch by phone) **
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest.
If you select them please specify your keywords in the box below:
Additonal questions or comments:



Copyright Targeted News Service 2021